4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-004508
SVP, CHIEF LEGAL OFFICER gave up 11,955 shares (to pay taxes)
- SVP, CHIEF LEGAL OFFICER acquired 22,205 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 2025-02-16 | Option exercise | +17,409 | 32,411 | D | ||
| Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 2025-02-16 | Shares withheld for taxes | −9,373 | $58.29 | $546,352 | 23,038 | D |
| Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 2025-02-16 | Option exercise | +4,796 | 27,834 | D | ||
| Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 2025-02-16 | Shares withheld for taxes | −2,582 | $58.29 | $150,505 | 25,252 | D |
| Derivatives | |||||||
| Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 2025-02-16 | Option exercise · Performance Stock Units | −17,409 | 0 | D | ||
| Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 2025-02-16 | Option exercise · Restricted Stock Units | −4,796 | 9,592 | D | ||
Loading xslF345X05/form4-02182025_110258.xml…